CY1122221T1 - Μεθοδοι αφαιρεσης ρυπου χρησιμοποιωντας ιοντοανταλλακτικη μεμβρανικη χρωματογραφια μετατοπισης γηγενων πρωτεϊνων - Google Patents

Μεθοδοι αφαιρεσης ρυπου χρησιμοποιωντας ιοντοανταλλακτικη μεμβρανικη χρωματογραφια μετατοπισης γηγενων πρωτεϊνων

Info

Publication number
CY1122221T1
CY1122221T1 CY20191101072T CY191101072T CY1122221T1 CY 1122221 T1 CY1122221 T1 CY 1122221T1 CY 20191101072 T CY20191101072 T CY 20191101072T CY 191101072 T CY191101072 T CY 191101072T CY 1122221 T1 CY1122221 T1 CY 1122221T1
Authority
CY
Cyprus
Prior art keywords
polypeptide
exchange membrane
ion
rough
proteins
Prior art date
Application number
CY20191101072T
Other languages
English (en)
Inventor
Arick Brown
Jerome Bill, Jr.
Timothy Tully
Christopher Dowd
Original Assignee
Genentech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39899038&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1122221(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech, Inc. filed Critical Genentech, Inc.
Publication of CY1122221T1 publication Critical patent/CY1122221T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Abstract

Περιγράφονται μέθοδοι καθαρισμού πολυπεπτιδίου από σύνθεση που περιλαμβάνει το πολυπεπτίδιο και τουλάχιστον ένα ρύπο, οι οποίες μέθοδοι περιλαμβάνουν τα εξής διαδοχικά στάδια: (a) διέλευση της σύνθεσης μέσω ιοντοανταλλακτικής μεμβράνης, όπου το πολυπεπτίδιο και η μεμβράνη έχουν αντίθετα φορτία, υπό συνθήκες λειτουργίας που αποτελούνται από ρυθμιστικό διάλυμα που έχει pΗ επαρκώς διαφορετικό από το ρI του πολυπεπτιδίου για να ενισχύεται το φορτίο του πολυπεπτιδίου και χαμηλή ιοντική ισχύ αποτελεσματική στο να αποτρέπει την θωράκιση φορτίων από ιόντα ρυθμιστικού διαλύματος, που προκαλούν την δέσμευση στην μεμβράνη του πολυπεπτιδίου και τουλάχιστον ενός ρύπου, και (b) ανάκτηση του καθαρισμένου πολυπεπτιδίου από την εκροή.
CY20191101072T 2008-08-14 2019-10-11 Μεθοδοι αφαιρεσης ρυπου χρησιμοποιωντας ιοντοανταλλακτικη μεμβρανικη χρωματογραφια μετατοπισης γηγενων πρωτεϊνων CY1122221T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14189582.1A EP2848625B1 (en) 2008-08-14 2008-08-14 Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography
PCT/US2008/073179 WO2010019148A1 (en) 2008-08-14 2008-08-14 Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography
EP08797895.3A EP2321337B2 (en) 2008-08-14 2008-08-14 Methods for removing a contaminant using protein displacement ion exchange membrane chromatography

Publications (1)

Publication Number Publication Date
CY1122221T1 true CY1122221T1 (el) 2020-11-25

Family

ID=39899038

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20191101072T CY1122221T1 (el) 2008-08-14 2019-10-11 Μεθοδοι αφαιρεσης ρυπου χρησιμοποιωντας ιοντοανταλλακτικη μεμβρανικη χρωματογραφια μετατοπισης γηγενων πρωτεϊνων

Country Status (21)

Country Link
US (2) US10927144B2 (el)
EP (3) EP3604324B1 (el)
JP (1) JP5666447B2 (el)
KR (3) KR102196883B1 (el)
CN (1) CN102149724B (el)
AU (1) AU2008360625C1 (el)
CA (1) CA2731943C (el)
CY (1) CY1122221T1 (el)
DK (2) DK3604324T3 (el)
ES (2) ES2527943T5 (el)
HK (1) HK1210181A1 (el)
HR (1) HRP20191848T1 (el)
HU (1) HUE047316T2 (el)
IL (2) IL210912B (el)
LT (1) LT2848625T (el)
MX (1) MX2011001506A (el)
PL (1) PL2848625T3 (el)
PT (1) PT2848625T (el)
RS (1) RS59232B1 (el)
SI (1) SI2848625T1 (el)
WO (1) WO2010019148A1 (el)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
AU2007294731B2 (en) 2006-09-13 2014-04-17 Abbvie Inc. Cell culture improvements
HUE047316T2 (hu) 2008-08-14 2020-04-28 Genentech Inc Eljárások szennyezés eltávolítására indigén fehérjekiszorításos ioncserés membrán kromatográfia alkalmazásával
CA2932207A1 (en) 2008-10-20 2010-12-09 Abbvie Inc. Isolation and purification of antibodies using protein a affinity chromatography
JP5856845B2 (ja) 2008-10-20 2016-02-10 アッヴィ・インコーポレイテッド 抗体精製中におけるウイルスの不活性化
ES2637613T5 (es) † 2010-05-25 2022-07-20 Hoffmann La Roche Procedimientos de purificación de polipéptidos
WO2012030512A1 (en) * 2010-09-03 2012-03-08 Percivia Llc. Flow-through protein purification process
KR20140092227A (ko) * 2010-12-10 2014-07-23 트레이시 톰슨 분리 방법용 조성물
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
TR201815709T4 (tr) * 2011-12-22 2018-11-21 Hoffmann La Roche İyon değişim membranı kromatografisi.
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
SG10201610955SA (en) * 2013-02-26 2017-02-27 Agency Science Tech & Res Protein purification in the presence of nonionic organic polymers and electropositive surfaces
EP2830651A4 (en) 2013-03-12 2015-09-02 Abbvie Inc HUMAN ANTIBODIES THAT BIND TNF-ALPHA AND PREPARATION METHODS
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
WO2014171437A1 (ja) * 2013-04-16 2014-10-23 旭化成メディカル株式会社 抗体タンパク質の精製方法
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
WO2015103545A1 (en) 2014-01-03 2015-07-09 Bio-Rad Laboratories, Inc. Removal of impurities from protein a eluates
BR112019004459A2 (pt) * 2016-09-07 2019-05-28 Glaxosmithkline Ip Dev Ltd métodos para purificar anticorpos
JP7085533B2 (ja) 2016-09-09 2022-06-16 スリーエム イノベイティブ プロパティズ カンパニー 官能化コポリマー及びその使用
US10053368B1 (en) * 2017-09-07 2018-08-21 Chevron U.S.A. Inc. Synthesis of AFX framework type molecular sieves
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
TW202348297A (zh) * 2018-05-02 2023-12-16 美商里珍納龍藥品有限公司 用於評估生化過濾器的適合性的方法
WO2019246153A1 (en) * 2018-06-19 2019-12-26 Bristol-Myers Squibb Company Methods of purifying proteins using chromatography
CN109324143B (zh) * 2018-10-19 2021-10-29 张骐 利用二维液相分离制备抗体类产品相关杂质的方法
CN109806916B (zh) * 2019-03-15 2021-12-21 中科森辉微球技术（苏州）有限公司 高性能阴离子交换介质及其制备方法
KR20220112014A (ko) 2021-02-03 2022-08-10 고인석 십전대보탕을 이용하여 만든 오리목뼈 간식

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US4347322A (en) † 1981-01-12 1982-08-31 Nabisco Brands, Inc. Chromatographic process for enzyme purification
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US5091178A (en) 1986-02-21 1992-02-25 Oncogen Tumor therapy with biologically active anti-tumor antibodies
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
DE68919361T2 (de) 1988-06-21 1995-05-24 Genentech Inc Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
DE68925971T2 (de) 1988-09-23 1996-09-05 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
CA2113813C (en) 1991-08-14 2005-04-12 Paula M. Jardieu Immunoglobulin variants for specific fc epsilon receptors
JPH07501451A (ja) 1991-11-25 1995-02-16 エンゾン・インコーポレイテッド 多価抗原結合タンパク質
AU675929B2 (en) 1992-02-06 1997-02-27 Curis, Inc. Biosynthetic binding protein for cancer marker
MX9305070A (es) 1992-08-21 1994-04-29 Genentech Inc Compocicion farmaceutica que contiene un antagonista de lfa-1 para el tratamiento de transtornos o desordenes mediados por el lfa-1
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
US5595721A (en) 1993-09-16 1997-01-21 Coulter Pharmaceutical, Inc. Radioimmunotherapy of lymphoma using anti-CD20
CA2106612C (en) † 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
WO1995016203A2 (en) 1993-12-10 1995-06-15 Genentech, Inc. Methods for diagnosis of allergy and screening of anti-allergy therapeutics
DK0739214T3 (da) 1994-01-18 1998-10-07 Genentech Inc Fremgangsmåde til behandling af parasitinfektionerunder anvendelse af IgE antagonister
WO1995023865A1 (en) 1994-03-03 1995-09-08 Genentech, Inc. Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
CA2222231A1 (en) 1995-06-07 1996-12-19 Imclone Systems Incorporated Antibody and antibody fragments for inhibiting the growth of tumors
EP1297847A3 (en) 1996-01-23 2003-05-07 Genentech, Inc. Anti-CD18 antibodies in stroke
WO1997027757A1 (en) 1996-01-31 1997-08-07 John Stephen Ayers Production of an immunoglobulin enriched fraction from whey protein solutions
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
IL130143A0 (en) 1996-11-27 2000-06-01 Genentech Inc Humanized anti-CD11a antibodies
EP0973804B1 (en) 1997-04-07 2006-12-27 Genentech, Inc. Anti-vegf antibodies
PT1860187E (pt) 1997-05-15 2011-10-04 Genentech Inc Receptor apo-2
ATE321066T1 (de) 1998-05-06 2006-04-15 Genentech Inc Anti-her2 antikörperzusammensetzung
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
IL149116A0 (en) 1999-10-29 2002-11-10 Genentech Inc Anti-prostate stem cell antigen (psca) antibody compositions and methods of use
US6479636B1 (en) * 2000-04-11 2002-11-12 Honiron Corporation (A Louisiana Corporation) Sugarcane fractioning system
US6633462B2 (en) 2000-07-13 2003-10-14 Koninklijke Philips Electronics N.V. Magnetoresistive angle sensor having several sensing elements
UA83458C2 (uk) 2000-09-18 2008-07-25 Байоджен Айдек Ма Інк. Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
GB2372464B (en) * 2001-02-22 2003-05-14 Vivascience Ltd Method of isolating a charged compound
US7321026B2 (en) 2001-06-27 2008-01-22 Skytech Technology Limited Framework-patched immunoglobulins
AU2002351495A1 (en) 2001-10-17 2003-04-28 Human Genome Sciences, Inc. Neutrokine-alpha and neutrokine-alpha splice variant
US20040093621A1 (en) 2001-12-25 2004-05-13 Kyowa Hakko Kogyo Co., Ltd Antibody composition which specifically binds to CD20
CA2476166C (en) 2002-02-14 2011-11-15 Immunomedics, Inc. Anti-cd20 antibodies and fusion proteins thereof and methods of use
CA2478925C (en) * 2002-04-26 2016-06-07 Robert Lee Fahrner Non-affinity purification of proteins
ES2558303T3 (es) * 2002-09-11 2016-02-03 Chugai Seiyaku Kabushiki Kaisha Método de purificación de proteínas
SI1558648T1 (sl) 2002-10-17 2012-05-31 Genmab As Človeška monoklonalna protitelesa proti CD
DE60332957D1 (de) 2002-12-16 2010-07-22 Genentech Inc Immunoglobulinvarianten und deren verwendungen
WO2005000901A2 (en) 2003-05-09 2005-01-06 Duke University Cd20-specific antibodies and methods of employing same
AR044388A1 (es) 2003-05-20 2005-09-07 Applied Molecular Evolution Moleculas de union a cd20
AU2004263538B2 (en) 2003-08-08 2009-09-17 Immunomedics, Inc. Bispecific antibodies for inducing apoptosis of tumor and diseased cells
US8147832B2 (en) 2003-08-14 2012-04-03 Merck Patent Gmbh CD20-binding polypeptide compositions and methods
EP1678208B1 (en) 2003-10-27 2013-05-15 Wyeth LLC Removal of high molecular weight aggregates using hydroxyapatite chromatography
MX2007009466A (es) 2005-02-10 2007-12-07 Baylor Res Inst Anticuerpos monoclonales de anti-interferon alfa y metodos para su uso.
MX2007011129A (es) 2005-03-11 2007-11-06 Wyeth Corp Un metodo de cromatografia de particion debil.
WO2007108955A1 (en) † 2006-03-20 2007-09-27 Medarex, Inc. Protein purification
EP2054521A4 (en) * 2006-10-03 2012-12-19 Novo Nordisk As METHODS OF PURIFYING CONJUGATES OF POLYPEPTIDES
WO2009135656A1 (en) 2008-05-06 2009-11-12 Lonza Biologics Plc. A method for the purification of antibodies using displacement chromatography
HUE047316T2 (hu) 2008-08-14 2020-04-28 Genentech Inc Eljárások szennyezés eltávolítására indigén fehérjekiszorításos ioncserés membrán kromatográfia alkalmazásával
JP5731726B1 (ja) 2014-06-26 2015-06-10 楽天株式会社 情報処理装置、情報処理方法及び情報処理プログラム

Also Published As

Publication number Publication date
SI2848625T1 (sl) 2019-11-29
BRPI0823046A2 (pt) 2015-07-28
IL210912B (en) 2019-03-31
EP2848625B1 (en) 2019-07-31
LT2848625T (lt) 2019-10-10
ES2749190T3 (es) 2020-03-19
HRP20191848T1 (hr) 2019-12-27
US20210284685A1 (en) 2021-09-16
CA2731943A1 (en) 2010-02-18
AU2008360625A1 (en) 2010-02-18
US10927144B2 (en) 2021-02-23
EP2321337B1 (en) 2014-10-22
DK2848625T3 (da) 2019-10-07
EP3604324A1 (en) 2020-02-05
KR20180137591A (ko) 2018-12-27
JP2011530592A (ja) 2011-12-22
PL2848625T3 (pl) 2020-01-31
MX2011001506A (es) 2011-03-15
KR102196883B1 (ko) 2020-12-30
IL210912A0 (en) 2011-04-28
KR20180033311A (ko) 2018-04-02
EP2848625A1 (en) 2015-03-18
KR101843915B1 (ko) 2018-04-02
IL262657B (en) 2021-03-25
CA2731943C (en) 2016-11-29
CN102149724A (zh) 2011-08-10
EP2321337B2 (en) 2018-10-10
DK3604324T3 (da) 2024-04-08
EP2321337A1 (en) 2011-05-18
EP2321337B9 (en) 2016-11-30
AU2008360625C1 (en) 2017-01-19
AU2008360625B2 (en) 2016-05-19
ES2527943T5 (es) 2019-03-07
EP3604324B1 (en) 2024-02-28
ES2527943T3 (es) 2015-02-02
WO2010019148A1 (en) 2010-02-18
KR20110067099A (ko) 2011-06-21
IL262657A (en) 2018-12-31
JP5666447B2 (ja) 2015-02-12
US20120122759A1 (en) 2012-05-17
RS59232B1 (sr) 2019-10-31
PT2848625T (pt) 2019-10-25
HK1210181A1 (en) 2016-04-15
CN102149724B (zh) 2014-04-09
HUE047316T2 (hu) 2020-04-28

Similar Documents

Publication Publication Date Title
CY1122221T1 (el) Μεθοδοι αφαιρεσης ρυπου χρησιμοποιωντας ιοντοανταλλακτικη μεμβρανικη χρωματογραφια μετατοπισης γηγενων πρωτεϊνων
ZA201903994B (en) Ion exchange membrane chromatography
CY1123952T1 (el) Απομονωση και καθαρισμος αντισωματων αντι-il-13 με την χρηση χρωματογραφιας χημικης συγγενειας πρωτεινης α
CY1120768T1 (el) Μεθοδος για καθαρισμο προκαρυωτικων παραλλαγων της αμμωνιακης λυασης της φαινυλαλανινης
RU2011137030A (ru) Способы очистки малых модулярных иммунофармацевтических белков
DK1780269T3 (da) Virusrensningsmetoder
BRPI0611600B8 (pt) método para purificação de uma proteína tendo uma região fc a partir de um líquido fonte compreendendo a proteína e uma ou mais impurezas, e kit
ATE384742T1 (de) Verfahren zur reinigung von preproinsulin
MX344268B (es) Proceso para purificacion de proteinas.
RU2014111820A (ru) Способы элиминации вируса
CY1116526T1 (el) Διαδικασια για καθαρισμο πρωτεϊνων
EA200970300A1 (ru) Способ и устройство для опреснения
WO2011106750A3 (en) Method and apparatus for enhanced lifetime and performance of ion source in an ion implantation system
ATE430195T1 (de) Verfahren und zusammensetzungen zur reinigung von nukleinsäure aus einer wirtszelle
DE602004023626D1 (de) Trennung von polypeptiden mit einer racemisierten aminosäure
ATE533838T1 (de) Verfahren zur verbesserten einführung von dna in bakterienzellen
MX368161B (es) Metodo para purificar el virus de rabia.
DK1844333T3 (da) Fremgangsmåde til eftervisning og fjernelse af endotoxiner
DK1851320T3 (da) Vacciner på basis af anvendelsen af MVA
DK1960521T3 (da) Fremgangsmåde og test kit til separation, oprensning og genvinding af lang- og kortkædede nukleinsyrer
ATE432946T1 (de) Abtrennung von fibrinogen von plasmaproteasen
FI3395423T3 (fi) Vuotaneen affiniteettipuhdistusligandin poistaminen
ATE449637T1 (de) Magnetische moleküle: funktionalisierte magnetische ferritine verwendendes verfahren zur selektiven beseitigung von verunreinigungen aus lösungen durch magnetfiltration
ATE496133T1 (de) Affinitätspolypeptid zur reinigung von rekombinanten proteinen
WO2008025558A3 (en) Affinity marker comprising a first and a second tag and its use